
Nathalie Vergnolle, director of research at Inserm, and her team at the Centre for Physiopathology at Toulouse Purpan (CPTP Inserm / Université Toulouse III – Paul Sabatier /CNRS), with Philippe Langella director of research at INRA and his team at the Institut Micalis[1], in collaboration with the Institut Pasteur, have recently succeeded in producing “beneficial bacteria” capable of protecting the body against intestinal inflammation.